The relative potency and safety of endothelial progenitor cells and unselected mononuclear cells for recovery from myocardial infarction and ischemia

Journal of Cellular Physiology
Haruki SekiguchiDouglas W Losordo

Abstract

Endothelial progenitor cells (EPCs) are a subset of the total mononuclear cell population (tMNCs) that possess an enhanced potential for differentiation within the endothelial-cell lineage. Typically, EPCs are selected from tMNCs via the expression of both hematopoietic stem-cell markers and endothelial-cell markers, such as CD34, or by culturing tMNCs in media selective for endothelial cells. Both EPCs and tMNCs participate in vascular growth and regeneration, and their potential use for treatment of myocardial injury or disease has been evaluated in early-phase clinical studies. Direct comparisons between EPCs and tMNCs are rare, but the available evidence appears to favor EPCs, particularly CD34+ cells, and the potency of EPCs may be increased as much as 30-fold through genetic modification. However, these observations must be interpreted with caution because clinical investigations of EPC therapy are ongoing. We anticipate that with continued development, EPC therapy will become a safe and effective treatment option for patients with acute myocardial infarction or chronic ischemic disease.

References

Jan 1, 1996·Chemical Immunology·A O'Garra, K Murphy
Aug 16, 2001·Proceedings of the National Academy of Sciences of the United States of America·D OrlicP Anversa
Dec 1, 2001·Trends in Cardiovascular Medicine·T Murohara
Mar 28, 2002·Proceedings of the National Academy of Sciences of the United States of America·Shulamit LevenbergRobert Langer
Sep 21, 2002·Lancet·Eriko Tateishi-YuyamaUNKNOWN Therapeutic Angiogenesis using Cell Transplantation (TACT) Study Investigators
Jan 9, 2003·Lancet·Christof StammGustav Steinhoff
Jan 30, 2003·Journal of Cardiac Failure·Annarosa LeriPiero Anversa
Aug 21, 2003·Proceedings of the National Academy of Sciences of the United States of America·Konrad UrbanekPiero Anversa
Sep 25, 2003·Cell·Antonio P BeltramiPiero Anversa
Oct 8, 2003·Proceedings of the National Academy of Sciences of the United States of America·Hidemasa OhMichael D Schneider
Oct 14, 2003·Nature·Manuel Alvarez-DoladoArturo Alvarez-Buylla
Jan 30, 2004·European Journal of Cardio-thoracic Surgery : Official Journal of the European Association for Cardio-thoracic Surgery·Shaoheng ZhangLinsong Li
Jun 12, 2004·Arteriosclerosis, Thrombosis, and Vascular Biology·Takahisa KondoToyoaki Murohara
Jul 3, 2004·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Rosanna BottaCesare Peschle

❮ Previous
Next ❯

Citations

Jun 19, 2013·Annals of Hematology·Daniel BarthelmesWeiyong Shen
May 26, 2011·Current Diabetes Reports·Lynn C ShawMaria B Grant
Apr 2, 2013·Endocrine·Maddalena GiliMaria Felice Brizzi
Jun 13, 2009·BMC Medicine·Alan Trounson
Dec 29, 2012·World Journal of Cardiology·Matina KoutroumpiSerafim Nanas
Dec 12, 2012·Imaging in Medicine·Branislava Janic, Ali S Arbab
May 30, 2013·Blood Cells, Molecules & Diseases·D BarthelmesW Y Shen
Nov 1, 2011·Naunyn-Schmiedeberg's Archives of Pharmacology·Clara Di FilippoMichele D'Amico
Mar 1, 2011·Progress in Retinal and Eye Research·Alan W StittReinhold J Medina
Jan 19, 2011·Cardiovascular Revascularization Medicine : Including Molecular Interventions·Gabriel P LasalaJose J Minguell
May 8, 2010·Experimental Hematology·Natascha K SchuhmannHildegard Büning
Dec 29, 2009·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Alberto ZambelliVittorio Rosti
Jan 2, 2010·Microvascular Research·Jeremy D Pearson
Nov 2, 2014·Journal of Clinical Periodontology·Hadar Zigdon-GiladiEli E Machtei
Apr 10, 2013·Gene·Anna Grochot-PrzeczekAlicja Jozkowicz
Aug 3, 2010·Journal of Molecular and Cellular Cardiology·Matthew R Richardson, Mervin C Yoder
Nov 19, 2011·Atherosclerosis·Susan ChengNaomi M Hamburg
May 3, 2012·Stem Cells International·Reinhold J MedinaAlan W Stitt
Apr 11, 2018·Journal of Cellular Biochemistry·Antonio FilippiniAlessio D'Alessio
Jun 13, 2012·Cellular Reprogramming·Virginia Picanço-CastroDimas Tadeu Covas
May 4, 2013·Arteriosclerosis, Thrombosis, and Vascular Biology·Jun Hee LeeSang Mo Kwon
Mar 20, 2010·Circulation Research·Yagna P R Jarajapu, Maria B Grant
Jan 21, 2017·Circulation Research·Bryon A TompkinsJoshua M Hare
Oct 30, 2010·Arteriosclerosis, Thrombosis, and Vascular Biology·H C de BoerA J van Zonneveld
Oct 17, 2009·Journal of Cardiovascular Pharmacology·Cristiano SpadaccioMassimo Chello
Jun 25, 2013·Biological Chemistry·Michael DonahueCarlo Briguori
Aug 26, 2017·International Orthopaedics·Erica M GilesAaron Nauth
Sep 21, 2010·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Eunju OYoung Ae Joe
Jul 9, 2020·Tissue Engineering. Part B, Reviews·Maximilian M MengerTina Histing
Oct 8, 2018·Journal of Molecular Neuroscience : MN·Harshini Chakravarthy, Vasudharani Devanathan
May 16, 2018·Stem Cells International·Alejandro CorreaPaulo Roberto Slud Brofman
Jan 21, 2021·Nature Reviews. Endocrinology·David A AntonettiAlan W Stitt

❮ Previous
Next ❯

Related Concepts

Related Feeds

Adult Stem Cells

Adult stem cells reside in unique niches that provide vital cues for their survival, self-renewal, and differentiation. They hold great promise for use in tissue repair and regeneration as a novel therapeutic strategies. Here is the latest research.

Cardiomyopathy

Cardiomyopathy is a disease of the heart muscle, that can lead to muscular or electrical dysfunction of the heart. It is often an irreversible disease that is associated with a poor prognosis. There are different causes and classifications of cardiomyopathies. Here are the latest discoveries pertaining to this disease.